Vanguard Reports 0 Shares of Alkermes Common Stock
Alkermes PLC Schedule 13G/A shows The Vanguard Group reports 0 shares beneficially owned of Alkermes PLC common stock and 0% of the class.
Rhea-AI Filing Summary
Alkermes PLC Schedule 13G/A shows The Vanguard Group reports 0 shares beneficially owned of Alkermes PLC common stock and 0% of the class. The filing notes an internal realignment effective January 12, 2026 under SEC Release No. 34-39538, after which certain Vanguard subsidiaries report holdings separately.
The amendment is a disclosure of ownership status and reorganization-related reporting changes; it does not show any current beneficial ownership or voting/dispositive power by The Vanguard Group over Alkermes PLC common stock.
Positive
- None.
Negative
- None.
Insights
The filing confirms no beneficial ownership by The Vanguard Group.
The filing states Amount beneficially owned: 0 and Percent of class: 0%, indicating Vanguard reports no current beneficial stake in Alkermes PLC common stock. The statement includes the January 12, 2026 realignment language referencing SEC Release No. 34-39538.
Cash-flow treatment and any prior holdings are not disclosed here; subsequent filings by Vanguard subsidiaries may show separate positions if present.
Amendment documents reporting structure changes, not a transaction.
The amendment explains that certain Vanguard subsidiaries now report holdings on a disaggregated basis following an internal realignment under SEC guidance. The filing asserts those subsidiaries pursue the same strategies previously pursued by The Vanguard Group, Inc.
This is a procedural disclosure about reporting attribution; it does not state any sale, acquisition, or change in Alkermes PLC ownership amount in this excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the significance of the January 12, 2026 realignment mentioned in the filing?
Does this Schedule 13G/A show any recent purchases or sales of ALKS by Vanguard?
Who signed the amendment on behalf of Vanguard and when?
Will separate filings from Vanguard subsidiaries show Alkermes holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.